Nutex Health (NUTX) Common Equity (2010 - 2026)

Nutex Health has disclosed Common Equity across 17 years of filings, most recently posting $442.1 million for Q1 2026.

• Common Equity for Q1 2026 came in at $442.1 million, up 73.17% year-over-year; the trailing twelve-month figure through Mar 2026 was $442.1 million (up 73.17% YoY), and the FY2025 annual result was $423.4 million, up 124.6% from the prior year.
• Common Equity came in at $442.1 million for Q1 2026 at Nutex Health, up from $423.4 million in the prior quarter.
• In the past five years, Common Equity ranged from a high of $556.1 million in Q2 2022 to a low of $79.1 million in Q4 2023.
• The 5-year median for Common Equity is $132.5 million (2022), against an average of $212.0 million.
• Across the five-year window, Common Equity plunged 80.54% in 2023 and jumped 310.72% in 2025, its largest moves.
• Nutex Health's Common Equity stood at $120.3 million in 2022, then plunged by 34.26% to $79.1 million in 2023, then jumped by 138.33% to $188.5 million in 2024, then jumped by 124.6% to $423.4 million in 2025, then climbed by 4.4% to $442.1 million in 2026.
• The last three Common Equity figures came in at $442.1 million (Q1 2026), $423.4 million (Q4 2025), and $317.2 million (Q3 2025), per Business Quant data.